{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:40:10Z","timestamp":1790188810045,"version":"4.1.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrep.2025.102148","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:50:11Z","timestamp":1753120211000},"page":"102148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment"],"prefix":"10.1016","volume":"43","author":[{"given":"Maryam","family":"Masoumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Solaymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheyda","family":"Houshmandfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnia","family":"Iravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Saeedi-Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2554-1669","authenticated-orcid":false,"given":"Jafar","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102148_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00251-011-0528-6","article-title":"Genetics of rheumatoid arthritis: what have we learned?","volume":"63","author":"Bax","year":"2011","journal-title":"Immunogenetics"},{"issue":"suppl_1","key":"10.1016\/j.bbrep.2025.102148_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.rheumatology.a031491","article-title":"New insights into the pathogenesis of rheumatoid arthritis","volume":"39","author":"Weyand","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbrep.2025.102148_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10753-020-01371-1","article-title":"Destructive roles of fibroblast-like synoviocytes in chronic inflammation and joint damage in rheumatoid arthritis","volume":"44","author":"Masoumi","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.bbrep.2025.102148_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107064","article-title":"Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: latest evidence and therapeutic approaches in rheumatoid arthritis","volume":"89","author":"Masoumi","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/annrheumdis-2018-213678","article-title":"Genetics of rheumatoid arthritis: 2018 status","volume":"78","author":"Okada","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrep.2025.102148_bib6","article-title":"Cuproptosis and cuproptosis\u2013related genes in rheumatoid arthritis: implication, prospects, and perspectives","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102400","article-title":"The etiology of rheumatoid arthritis","volume":"110","author":"Scherer","year":"2020","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis\u2014common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrep.2025.102148_bib9","first-page":"23","article-title":"Features of the psychoemotional status of patients with rheumatoid arthritis","volume":"32","author":"Rustamovich","year":"2023","journal-title":"Miasto Przysz\u0142o\u015bci"},{"key":"10.1016\/j.bbrep.2025.102148_bib10","first-page":"1","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbrep.2025.102148_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2019.03.033","article-title":"Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review","volume":"702","author":"Karami","year":"2019","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5312\/wjo.v5.i4.544","article-title":"Rheumatoid arthritis susceptibility genes: an overview","volume":"5","author":"Korczowska","year":"2014","journal-title":"World J. Orthoped."},{"issue":"4 Suppl 92","key":"10.1016\/j.bbrep.2025.102148_bib13","first-page":"S40","article-title":"From genetics to functional insights into rheumatoid arthritis","volume":"33","author":"Suzuki","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/cge.13498","article-title":"The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis","volume":"95","author":"Zamanpoor","year":"2019","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/keu323","article-title":"The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA","volume":"55","author":"Yarwood","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbrep.2025.102148_bib16","series-title":"Genetics of Rheumatoid Arthritis","year":"2022"},{"key":"10.1016\/j.bbrep.2025.102148_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2384","article-title":"Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets","volume":"10","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17460441.2020.1682992","article-title":"The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery","volume":"15","author":"Machaj","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/biom13050766","article-title":"New targets and strategies for rheumatoid arthritis: from signal transduction to epigenetic aspect","volume":"13","author":"Zhu","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imcb.12311","article-title":"Epigenetics in rheumatoid arthritis; fibroblast\u2010like synoviocytes as an emerging paradigm in the pathogenesis of the disease","volume":"98","author":"Karami","year":"2020","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/ijms17060900","article-title":"Rheumatoid arthritis: the stride from research to clinical practice","volume":"17","author":"Chung","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.55563\/clinexprheumatol\/l9lyen","article-title":"Pathogenesis of rheumatoid arthritis: one year in review 2022","volume":"40","author":"Petrelli","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/cells9051127","article-title":"Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis\u2013from research to clinical practice","volume":"9","author":"Wysocki","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib24","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","article-title":"The genetics of rheumatoid arthritis","volume":"59","author":"Dedmon","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbrep.2025.102148_bib25","series-title":"Seminars in Immunopathology","article-title":"HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases","year":"2022"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101499","article-title":"HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis","volume":"33","author":"Xu","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2183\/pjab.91.410","article-title":"Genetic studies of rheumatoid arthritis","volume":"91","author":"Yamamoto","year":"2015","journal-title":"Proceedings of the Japan Academy, Series B"},{"key":"10.1016\/j.bbrep.2025.102148_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","article-title":"Role of human leukocyte antigens (HLA) in autoimmune diseases","volume":"5","author":"Bodis","year":"2018","journal-title":"Rheumatol. ther."},{"key":"10.1016\/j.bbrep.2025.102148_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178546","article-title":"Association of Human Leukocyte Antigen (HLA) class II (DRB1 and DQB1) alleles and haplotypes with Rheumatoid Arthritis in Sudanese patients","volume":"14","author":"Ali","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijsu.2018.01.046","article-title":"Association of HLA-DPB1 polymorphisms with rheumatoid arthritis: a systemic review and meta-analysis","volume":"52","author":"Jiang","year":"2018","journal-title":"Int. J. Surg."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102148_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204459","article-title":"Independent association of HLA-DPB1\u2217 02: 01 with rheumatoid arthritis in Japanese populations","volume":"13","author":"Furukawa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102148_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","article-title":"Genetics of rheumatoid arthritis\u2014a comprehensive review","volume":"45","author":"Kurk\u00f3","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/cells9020475","article-title":"The impact of cigarette smoking on risk of rheumatoid arthritis: a narrative review","volume":"9","author":"Ishikawa","year":"2020","journal-title":"Cells"},{"issue":"1104","key":"10.1016\/j.bbrep.2025.102148_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/postgradmedj-2016-134724","article-title":"Association of HLA-DQB1 polymorphisms with rheumatoid arthritis: a meta-analysis","volume":"93","author":"Wu","year":"2017","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bbrep.2025.102148_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.imlet.2019.10.010","article-title":"PTPN22 1858 C\/T polymorphism is associated with alteration of cytokine profiles as a potential pathogenic mechanism in rheumatoid arthritis","volume":"216","author":"Ghorban","year":"2019","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14728222.2018.1526924","article-title":"The potential of PTPN22 as a therapeutic target for rheumatoid arthritis","volume":"22","author":"Carmona","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/art.40790","article-title":"The contribution of PTPN22 to rheumatic disease","volume":"71","author":"Mustelin","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/s10165-012-0639-4","article-title":"PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis","volume":"23","author":"Hou","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.arcmed.2015.05.011","article-title":"Associations between PADI4 gene polymorphisms and rheumatoid arthritis: an updated meta-analysis","volume":"46","author":"Yang","year":"2015","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.sjbs.2021.09.037","article-title":"Novel functional polymorphism on PADI-4 gene and its association with arthritis onset","volume":"29","author":"Maryam Mukhtar","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193674","article-title":"Peptidylarginine deiminase 4-104C\/T polymorphism and risk of rheumatoid arthritis: a pooled analysis based on different populations","volume":"13","author":"Hua","year":"2018","journal-title":"PLoS One"},{"issue":"42","key":"10.1016\/j.bbrep.2025.102148_bib42","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17746","article-title":"A single nucleotide polymorphism of AIRE gene located in the 21q22. 3 increases the risk of rheumatoid arthritis","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2017.10.017","article-title":"Beyond APECED: an update on the role of the autoimmune regulator gene (AIRE) in physiology and disease","volume":"17","author":"Conteduca","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrep.2025.102148_bib44","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187944","article-title":"The rs878081 polymorphism of AIRE gene increases the risk of rheumatoid arthritis in a Chinese Han population: a case-control study","volume":"51","author":"Yang","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"15","key":"10.1016\/j.bbrep.2025.102148_bib45","article-title":"Association between CTLA-4 gene polymorphism and risk of rheumatoid arthritis: a meta-analysis","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/13813455.2016.1230135","article-title":"Cytotoxic T-lymphocyte-associated protein 4 gene polymorphism is related to rheumatoid arthritis in Egyptian population","volume":"123","author":"Fattah","year":"2017","journal-title":"Arch. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.24412","article-title":"CTLA4\/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population","volume":"60","author":"Walker","year":"2009","journal-title":"Arthritis Rheum.: Official Journal of the American College of Rheumatology"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jrms.JRMS_567_20","article-title":"Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: a systematic review and meta-analysis","volume":"26","author":"Mousavi","year":"2021","journal-title":"J. Res. Med. Sci."},{"issue":"5\u20136","key":"10.1016\/j.bbrep.2025.102148_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000526212","article-title":"Associations between TNFAIP3 polymorphisms and rheumatoid arthritis: a systematic review and meta-analysis update with trial sequential analysis","volume":"25","author":"Lee","year":"2022","journal-title":"Public Health Genom."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib50","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1038\/s41598-020-61331-5","article-title":"NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: results from the REPAIR consortium","volume":"10","author":"Manuel S\u00e1nchez-Maldonado","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.humimm.2012.11.033","article-title":"Association between polymorphism in STAT4 gene and risk of rheumatoid arthritis: a meta-analysis","volume":"74","author":"Tong","year":"2013","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib52","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/art.24721","article-title":"Association of a single\u2010nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis","volume":"60","author":"Van Der Linden","year":"2009","journal-title":"Arthritis Rheum.: Official Journal of the American College of Rheumatology"},{"key":"10.1016\/j.bbrep.2025.102148_bib53","article-title":"Association of CD40 gene polymorphisms with systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib54","article-title":"Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib55","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/ijms23042106","article-title":"Proinflammatory cytokines (IL-1,-6,-8,-15,-17,-18,-23, TNF-\u03b1) single nucleotide polymorphisms in rheumatoid arthritis\u2014a literature review","volume":"23","author":"Koper-Lenkiewicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/21691401.2019.1579731","article-title":"Associations between IL-23R gene polymorphisms and the susceptibility of rheumatoid arthritis: a meta-analysis","volume":"47","author":"Zou","year":"2019","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00296-021-04881-9","article-title":"IL-23R gene polymorphisms in rheumatoid arthritis","volume":"42","author":"Soysal","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbrep.2025.102148_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108250","article-title":"The association between genetic polymorphisms of interleukin 23 receptor gene and the risk of rheumatoid arthritis: an updated meta-analysis","volume":"210","author":"Du","year":"2020","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5496\/wjmg.v11.i3.28","article-title":"Role of IL-2\/IL-2 receptor in pathogenesis of autoimmune disorders: genetic and therapeutic aspects","volume":"11","author":"Rafaqat","year":"2023","journal-title":"World J. Med. Genet."},{"issue":"14","key":"10.1016\/j.bbrep.2025.102148_bib60","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.3390\/ijms21144911","article-title":"Genetic polymorphisms associated with rheumatoid arthritis development and antirheumatic therapy response","volume":"21","author":"Mikhaylenko","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2025.102148_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2013.00321","article-title":"MHC class II polymorphisms, autoreactive T-cells, and autoimmunity","volume":"4","author":"Tsai","year":"2013","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102148_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3204","article-title":"PTPN22 gene polymorphism and susceptibility to rheumatoid arthritis (RA): updated systematic review and meta\u2010analysis","volume":"22","author":"Abbasifard","year":"2020","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbrep.2025.102148_bib63","series-title":"Seminars in Arthritis and Rheumatism","article-title":"The role of PTPN22 in the pathogenesis of autoimmune diseases: a comprehensive review","year":"2021"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/medicina58081034","article-title":"Genetic polymorphism of PTPN22 in autoimmune diseases: a comprehensive review","volume":"58","author":"Tizaoui","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.bbrep.2025.102148_bib65","article-title":"Role of the PADI family in inflammatory autoimmune diseases and cancers: a systematic review","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.autrev.2017.11.023","article-title":"Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis","volume":"17","author":"Reyes-Castillo","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrep.2025.102148_bib67","first-page":"259","article-title":"Single nucleotide polymorphism rs2075876 in AIRE gene is a strong rheumatoid arthritis determinant","author":"Salesi","year":"2021","journal-title":"Acta Med. Iran."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14375-z","article-title":"Association between AIRE gene polymorphism and rheumatoid arthritis: a systematic review and meta-analysis of case-control studies","volume":"7","author":"B\u00e9rczi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102148_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: from mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.55133\/eji.300318","article-title":"Evaluation of CTLA-4 (+ 49A\/G) polymorphism association with rheumatoid arthritis in Egyptian patients","volume":"30","author":"Ragab","year":"2023","journal-title":"Egypt. J. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib71","article-title":"NF-\u03bab and rheumatoid arthritis: will understanding genetic risk lead to a therapeutic reward?","volume":"4","author":"Scheinman","year":"2013","journal-title":"Onco Therapeutics"},{"key":"10.1016\/j.bbrep.2025.102148_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu","year":"2021","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102148_bib73","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/1756-185X.13958","article-title":"Nuclear factor\u2010\u03baB in rheumatoid arthritis","volume":"23","author":"Li","year":"2020","journal-title":"nt. J. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102148_bib74","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7150\/ijbs.41852","article-title":"STAT4: an immunoregulator contributing to diverse human diseases","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib75","first-page":"71","article-title":"Studying the association between STAT4 gene polymorphism and susceptibility to rheumatoid arthritis disease: an updated meta-analysis","volume":"16","author":"Ebrahimiyan","year":"2019","journal-title":"Iran. J. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.injr.2016.02.002","article-title":"STAT4 rs7574865 polymorphism in Iranian patients with rheumatoid arthritis","volume":"11","author":"Alizadeh","year":"2016","journal-title":"Indian J. Rheumatol."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib77","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/ph15080941","article-title":"Interaction between mesenchymal stem cells and the immune system in rheumatoid arthritis","volume":"15","author":"Ba\u010denkov\u00e1","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrep.2025.102148_bib78","series-title":"Seminars in Immunology","article-title":"CD40 and autoimmunity: the dark side of a great activator","year":"2009"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib79","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of rheumatoid arthritis","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/1389450120666191114102830","article-title":"CD28: a new drug target for immune disease","volume":"21","author":"Xia","year":"2020","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib81","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40246-022-00419-7","article-title":"rs2013278 in the multiple immunological-trait susceptibility locus CD28 regulates the production of non-functional splicing isoforms","volume":"16","author":"Hitomi","year":"2022","journal-title":"Hum. Genom."},{"key":"10.1016\/j.bbrep.2025.102148_bib82","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14046.1","article-title":"CD28 between tolerance and autoimmunity: the side effects of animal models","volume":"7","author":"Porciello","year":"2018","journal-title":"F1000Research"},{"issue":"24","key":"10.1016\/j.bbrep.2025.102148_bib83","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1093\/hmg\/ddac178","article-title":"A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South Africa","volume":"31","author":"Mathebula","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41435-021-00134-8","article-title":"HLA-DRB1, IRF5, and CD28 gene polymorphisms in Egyptian patients with rheumatoid arthritis: susceptibility and disease activity","volume":"22","author":"Said","year":"2021","journal-title":"Gene Immun."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib85","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/eji.201646787","article-title":"The role of IL\u201023 receptor signaling in inflammation\u2010mediated erosive autoimmune arthritis and bone remodeling","volume":"48","author":"Razawy","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"52","key":"10.1016\/j.bbrep.2025.102148_bib86","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002361","article-title":"Association of IL-23R polymorphisms (rs6682925, rs10889677, rs1884444) with cancer risk: a PRISMA-compliant meta-analysis","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib87","first-page":"13","article-title":"Association of IL-23R gene rs7517847 T> G SNP and susceptibility to systemic lupus erythematosus: a systematic review and meta-analysis","volume":"3","author":"Imani","year":"2018","journal-title":"Arthritis Res."},{"key":"10.1016\/j.bbrep.2025.102148_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1247710","article-title":"Causal relationships between CD25 on immune cells and hip osteoarthritis","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-014-0514-0","article-title":"IL2RA is associated with persistence of rheumatoid arthritis","volume":"17","author":"Van Steenbergen","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/bbrj.bbrj_147_19","article-title":"Rheumatoid arthritis identification using epistasis analysis through computational models","volume":"4","author":"Manavalan","year":"2020","journal-title":"Biomed. Biotechnol. Res. J. (BBRJ)"},{"key":"10.1016\/j.bbrep.2025.102148_bib91","series-title":"2010 3rd International Conference on Biomedical Engineering and Informatics","article-title":"Genome-wide gene-gene interaction analysis of rheumatoid arthritis","year":"2010"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib92","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gene.2016.02.004","article-title":"Genetic data: the new challenge of personalized medicine, insights for rheumatoid arthritis patients","volume":"583","author":"Goulielmos","year":"2016","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2015.02.011","article-title":"Gene\u2013gene interaction and RNA splicing profiles of MAP2K4 gene in rheumatoid arthritis","volume":"158","author":"Shchetynsky","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib94","series-title":"Between the Lines of Genetic Code","first-page":"85","article-title":"Gene\u2013Gene and gene\u2013environment interaction in rheumatoid arthritis","author":"Padyukov","year":"2014"},{"key":"10.1016\/j.bbrep.2025.102148_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3051","article-title":"Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study","volume":"12","author":"Bang","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbrep.2025.102148_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.747274","article-title":"MicroRNA variants and HLA-miRNA interactions are novel rheumatoid arthritis susceptibility factors","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib97","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.autrev.2018.11.005","article-title":"The study of interactions between genome and exposome in the development of systemic lupus erythematosus","volume":"18","author":"Leffers","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib98","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/joim.13058","article-title":"The importance of differences; on environment and its interactions with genes and immunity in the causation of rheumatoid arthritis","volume":"287","author":"Klareskog","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrep.2025.102148_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.689698","article-title":"Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review","volume":"8","author":"Rom\u00e3o","year":"2021","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib100","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/jcm9103109","article-title":"Environment and lifestyle: their influence on the risk of RA","volume":"9","author":"Salliot","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib101","doi-asserted-by":"crossref","first-page":"404","DOI":"10.31138\/mjr.301223.eaf","article-title":"Epidemiology and risk factors for Rheumatoid arthritis development","volume":"34","author":"Venetsanopoulou","year":"2023","journal-title":"Mediterr J Rheumatol."},{"key":"10.1016\/j.bbrep.2025.102148_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1276-2","article-title":"DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis","volume":"19","author":"Meng","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib103","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/cells8070700","article-title":"Mucosa\u2013Environment interactions in the pathogenesis of rheumatoid arthritis","volume":"8","author":"Lucchino","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrep.2025.102148_bib104","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10067-012-2154-6","article-title":"Severe deficiency of 25-hydroxyvitamin D 3 (25-OH-D 3) is associated with high disease activity of rheumatoid arthritis","volume":"32","author":"Haga","year":"2013","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ncprheum0855","article-title":"Control of autoimmune diseases by the vitamin D endocrine system","volume":"4","author":"Adorini","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib106","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/nu14020360","article-title":"Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: a systematic review and meta-analysis","volume":"14","author":"Usategui-Mart\u00edn","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis\u2014shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib108","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13104-023-06559-w","article-title":"Some genetic differences in patients with rheumatoid arthritis","volume":"16","author":"Ahmad","year":"2023","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.bbrep.2025.102148_bib109","article-title":"Association of vitamin D receptor gene polymorphisms with rheumatoid arthritis","author":"Pete","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.berh.2015.02.002","article-title":"Role of genetics in infection-associated arthritis","volume":"29","author":"Benham","year":"2015","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib111","article-title":"Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis","volume":"2017","author":"Horta-Baas","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib112","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-023-03248-8","article-title":"Patients with obesity have more inflamed joints and higher CRP levels during the disease course in ACPA-positive RA but not in ACPA-negative RA","volume":"26","author":"Hollander","year":"2024","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89618-1","article-title":"Exploring the effect of alcohol on disease activity and outcomes in rheumatoid arthritis through systematic review and meta-analysis","volume":"11","author":"Turk","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102148_bib114","article-title":"The relationship between porphyromonas gingivalis and rheumatoid arthritis: a meta-analysis","volume":"12","author":"Li","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.bbrep.2025.102148_bib115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.autrev.2018.05.007","article-title":"The role of dietary sodium in autoimmune diseases: the salty truth","volume":"17","author":"Sharif","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib116","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18683\/germs.2021.1263","article-title":"Periodontal disease in seropositive rheumatoid arthritis: scoping review of the epidemiological evidence","volume":"11","author":"Nik-Azis","year":"2021","journal-title":"Germs"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib117","article-title":"Biomarkers in rheumatoid arthritis","volume":"13","author":"Shapiro","year":"2021","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195550","article-title":"Clinical management of seronegative and seropositive rheumatoid arthritis: a comparative study","volume":"13","author":"Choi","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib119","first-page":"554","article-title":"Seronegative rheumatoid arthritis: one year in review 2023","volume":"41","author":"De Stefano","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-genom-090314-045919","article-title":"Recent advances in defining the genetic basis of rheumatoid arthritis","volume":"17","author":"Terao","year":"2016","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.bbrep.2025.102148_bib121","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fmed.2018.00186","article-title":"Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: microRNA signature, histological, and ultrasound features","volume":"5","author":"Alivernini","year":"2018","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-020-04665-7","article-title":"Immune checkpoint inhibitor-induced musculoskeletal manifestations","volume":"41","author":"Angelopoulou","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"22","key":"10.1016\/j.bbrep.2025.102148_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212386","article-title":"The genetic, environmental, and immunopathological complexity of autoantibody-negative rheumatoid arthritis","volume":"22","author":"De Stefano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib124","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/s41467-022-31519-6","article-title":"Single cell sequencing identifies clonally expanded synovial CD4+ TPH cells expressing GPR56 in rheumatoid arthritis","volume":"13","author":"Argyriou","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/ard.2004.023929","article-title":"Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography","volume":"64","author":"Naredo","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrep.2025.102148_bib126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00296-016-3587-z","article-title":"The role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review","volume":"37","author":"Lage-Hansen","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib127","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrep.2025.102148_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.medengphy.2022.103839","article-title":"Evaluation of tenosynovitis in patients with seronegative rheumatoid arthritis using microvascular flow imaging","volume":"110","author":"Wang","year":"2022","journal-title":"Med. Eng. Phys."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","article-title":"Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset","volume":"81","author":"Saevarsdottir","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrep.2025.102148_bib130","series-title":"Seminars in Arthritis and Rheumatism","article-title":"Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation","year":"2022"},{"issue":"12","key":"10.1016\/j.bbrep.2025.102148_bib131","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib132","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1136\/annrheumdis-2013-204591","article-title":"A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides","volume":"74","author":"Bossini-Castillo","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrep.2025.102148_bib133","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15690","article-title":"In silico analysis of serum miRNA profiles in seronegative and seropositive rheumatoid arthritis patients by small RNA sequencing","volume":"11","author":"He","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrep.2025.102148_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.838884","article-title":"MicroRNA-mediated epigenetic regulation of rheumatoid arthritis susceptibility and pathogenesis","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102148_bib135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14737159.2017.1355732","article-title":"The role of genetic analysis for predicting outcome of rheumatoid arthritis","volume":"17","author":"Chaudhry","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223246","article-title":"Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases","volume":"14","author":"Traylor","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib137","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3899\/jrheum.141211","article-title":"Do genetic susceptibility variants associate with disease severity in early active rheumatoid arthritis?","volume":"42","author":"Scott","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbrep.2025.102148_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0830-z","article-title":"PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts","volume":"17","author":"Rodriguez-Rodriguez","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbrep.2025.102148_bib139","doi-asserted-by":"crossref","DOI":"10.1186\/s13317-020-00145-x","article-title":"Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe","author":"Mousavi","year":"2021","journal-title":"Autoimmun Highlights"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib140","first-page":"453","article-title":"Evaluation of TAK-242 (Resatorvid) effects on inflammatory status of fibroblast-like synoviocytes in rheumatoid arthritis and trauma patients","volume":"20","author":"Karami","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib141","first-page":"338","article-title":"Role of fibroblast activation protein alpha in fibroblast-like synoviocytes of rheumatoid arthritis","volume":"20","author":"Mousavi","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib142","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib143","first-page":"30","article-title":"Association of the A allele of the TNF-Alpha-308 G\/A gene polymorphism with radiographic progression in rheumatoid arthritis","volume":"35","author":"Stojanovi\u0107","year":"2018","journal-title":"Acta Fac. Med. Naissensis"},{"key":"10.1016\/j.bbrep.2025.102148_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-014-0514-0","article-title":"A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis","volume":"17","author":"van Steenbergen","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbrep.2025.102148_bib145","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00198-018-4625-3","article-title":"LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients","volume":"29","author":"Bernardes","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib146","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/art.38064","article-title":"Allele\u2010dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis","volume":"65","author":"Teare","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib147","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/art.22814","article-title":"Association of interleukin\u20106 and interleukin\u201010 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status","volume":"56","author":"Marinou","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13317-021-00152-6","article-title":"Potential clinical biomarkers in rheumatoid arthritis with an omic approach","volume":"12","author":"Puentes-Osorio","year":"2021","journal-title":"Autoimmunity Highlights"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib149","first-page":"512","article-title":"Biomarkers in rheumatoid arthritis","volume":"19","author":"Atzeni","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bbrep.2025.102148_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0652-z","article-title":"Early biomarkers of joint damage in rheumatoid and psoriatic arthritis","volume":"17","author":"Mc Ardle","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib151","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: advances in treatment strategies","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102148_bib152","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrrheum.2011.117","article-title":"Pharmacogenetics: implications for therapy in rheumatic diseases","volume":"7","author":"Davila","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib153","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.tpj.6500438","article-title":"Reduced folate carrier-1 80G> A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis","volume":"7","author":"Drozdzik","year":"2007","journal-title":"Pharmacogenomics J."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib154","first-page":"546","article-title":"ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients","volume":"24","author":"Takatori","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108165","article-title":"Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients","volume":"9","author":"Lima","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbrep.2025.102148_bib156","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2217\/14622416.8.11.1551","article-title":"677C> T and 1298A> C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis","volume":"8","author":"Kurzawski","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbrep.2025.102148_bib157","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12026-013-8405-z","article-title":"Pharmacogenetics and pharmacogenomics in rheumatology","volume":"56","author":"Szekanecz","year":"2013","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib159","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/biomedicines11051262","article-title":"Pathogenesis of extraarticular manifestations in rheumatoid arthritis\u2014A comprehensive review","volume":"11","author":"Mitrovi\u0107","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102148_bib160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/jcm10030509","article-title":"The key comorbidities in patients with rheumatoid arthritis: a narrative review","volume":"10","author":"Taylor","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib161","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-023-03140-5","article-title":"Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease","volume":"25","author":"Shao","year":"2023","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib162","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/1744666X.2021.1905524","article-title":"Rheumatoid arthritis related interstitial lung disease","volume":"17","author":"Manfredi","year":"2021","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"160","key":"10.1016\/j.bbrep.2025.102148_bib163","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bbrep.2025.102148_bib164","series-title":"Breathing New Life into Interstitial Lung Disease in Rheumatoid Arthritis","first-page":"2265","author":"Gregersen","year":"2018"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41232-024-00345-2","article-title":"Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease","volume":"44","author":"Nishioka","year":"2024","journal-title":"Inflamm. Regen."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102148_bib166","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/annrheumdis-2020-217256","article-title":"Association of the RPA3-UMAD1 locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese","volume":"79","author":"Shirai","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib167","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/jcm10071384","article-title":"Telomeres in interstitial lung disease","volume":"10","author":"Stock","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102148_bib168","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2020","article-title":"Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Matson","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"27","key":"10.1016\/j.bbrep.2025.102148_bib170","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2174\/0929867329666220907151213","article-title":"Immunometabolism dysfunction in the pathophysiology and treatment of rheumatoid arthritis","volume":"30","author":"Masoumi","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib171","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10753-022-01751-9","article-title":"Role of T cells in the pathogenesis of rheumatoid arthritis: focus on immunometabolism dysfunctions","volume":"46","author":"Masoumi","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.bbrep.2025.102148_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117734","article-title":"Role of autophagy in the pathogenesis of rheumatoid arthritis: latest evidence and therapeutic approaches","volume":"254","author":"Karami","year":"2020","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib173","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/jcm8060826","article-title":"The potential role of genomic medicine in the therapeutic management of rheumatoid arthritis","volume":"8","author":"Acosta-Herrera","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib174","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"234","author":"Abbasi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102148_bib175","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/biom10121672","article-title":"Biomarkers to personalize the treatment of rheumatoid arthritis: focus on autoantibodies and pharmacogenetics","volume":"10","author":"Conti","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib176","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jcph.1341","article-title":"FCGR2A\/FCGR3A gene polymorphisms and clinical variables as predictors of response to tocilizumab and rituximab in patients with rheumatoid arthritis","volume":"59","author":"Jim\u00e9nez Morales","year":"2019","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib177","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/genes13071284","article-title":"Genetic biomarkers as predictors of response to tocilizumab in rheumatoid arthritis: a systematic review and meta-analysis","volume":"13","author":"Janahiraman","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42324-6","article-title":"Carriers of HLA-DRB1\u2217 04: 05 have a better clinical response to abatacept in rheumatoid arthritis","volume":"13","author":"Inoue","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102148_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738481","article-title":"Tofacitinib suppresses several JAK-STAT pathways in rheumatoid arthritis in vivo and baseline signaling profile associates with treatment response","volume":"12","author":"Palmroth","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108794","article-title":"An update on novel therapeutic intervention in Rheumatoid arthritis","volume":"109","author":"Shah","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrep.2025.102148_bib181","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","article-title":"Tofacitinib: a review in rheumatoid arthritis","volume":"77","author":"Dhillon","year":"2017","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib182","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.autrev.2019.05.007","article-title":"Challenges in the treatment of rheumatoid arthritis","volume":"18","author":"Conigliaro","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102148_bib183","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/biomedicines11071987","article-title":"DNA methylation signatures of response to conventional synthetic and biologic disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis","volume":"11","author":"Wang","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrep.2025.102148_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118907","article-title":"The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis","volume":"268","author":"Gao","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102148_bib185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1303006","article-title":"Therapies for active rheumatoid arthritis after methotrexate failure","volume":"369","author":"O'Dell","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib186","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/cells10020323","article-title":"Biologic drugs for rheumatoid arthritis in the context of biosimilars, genetics, epigenetics and COVID-19 treatment","volume":"10","author":"Bonek","year":"2021","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.bbrep.2025.102148_bib187","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.3390\/ijms21239067","article-title":"Effects of biological therapies on molecular features of rheumatoid arthritis","volume":"21","author":"Lopez-Pedrera","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2025.102148_bib188","article-title":"Anti-rheumatoid drugs advancements: new insights into the molecular treatment of rheumatoid arthritis","volume":"151","author":"Mrid","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102148_bib189","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/cells9081876","article-title":"Small molecule inhibitors in the treatment of rheumatoid arthritis and beyond: latest updates and potential strategy for fighting COVID-19","volume":"9","author":"Massalska","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40744-017-0073-3","article-title":"Treatment with biologicals in rheumatoid arthritis: an overview","volume":"4","author":"Rein","year":"2017","journal-title":"Rheumatol. ther."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102148_bib191","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002570","article-title":"Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review","volume":"8","author":"Wientjes","year":"2022","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102148_bib192","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrep.2025.102148_bib193","article-title":"Promising therapeutic targets for treatment of rheumatoid arthritis","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2025.102148_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.680043","article-title":"The therapeutic landscape of rheumatoid arthritis: current state and future directions","volume":"12","author":"Shams","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbrep.2025.102148_bib195","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"issue":"36","key":"10.1016\/j.bbrep.2025.102148_bib196","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj1414","article-title":"A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery","volume":"7","author":"Choi","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrep.2025.102148_bib197","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221076211","article-title":"A broad look into the future of rheumatoid arthritis","volume":"14","author":"Mucke","year":"2022","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"key":"10.1016\/j.bbrep.2025.102148_bib198","first-page":"15","article-title":"Pharmacogenetics of rheumatoid arthritis: potential targets from susceptibility genes and present therapies","author":"O'Rielly","year":"2010","journal-title":"Pharmacogenomics Personalized Med."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102148_bib199","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.farma.2023.12.004","article-title":"Exploring the impact of pharmacogenetics on personalized medicine: a systematic review","volume":"48","author":"Amaro-\u00c1lvarez","year":"2024","journal-title":"Farmac Hosp."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825002353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825002353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:37:53Z","timestamp":1767191873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825002353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":199,"alternative-id":["S2405580825002353"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102148","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102148"}}